Skip to main content

Anne L. Bruno

Member

[email protected]

+1.617.832.6565

Share:

Anne Bruno’s practice leverages her deep expertise in both corporate and employment law. She is skilled in her ability to advise on issues that affect both public and private companies from startups to established multinational companies in a broad range of industries.

On the corporate side of her practice, Anne has extensive experience advising on the intricacies of the federal securities laws. Anne advises public companies and registrants in preparing required disclosure filings and shareholder materials, including considering disclosure requirements of director and executive compensation, understanding cybersecurity and AI issues, and addressing institutional investors and proxy advisory firm considerations.

On the employment side of Anne’s practice, she counsels clients on creating, implementing, and administering equity and executive compensation arrangements and programs, including: equity plans, phantom equity arrangements, incentive plans, deferred compensation plans, change-in-control arrangements, and severance and employment agreements.

She also advises with respect to tax, corporate, and securities law concerns that arise in connection with employment plans and arrangements. She advises and represents a broad range of public and private companies, boards of directors, and compensation committees in these matters. She also counsels executives with negotiation of their compensation packages and works closely with senior executives and founders to implement 10b5-1 plans and complex diversification strategies. 

Additionally, Anne brings her expertise to corporate financings and transactions. She has played a significant role in public offerings, merger and acquisition transactions, and reverse merger and special purpose acquisition companies (SPAC) transactions. She has represented companies and executives in connection with complex employee benefits and compensation-related aspects of these transactions. She also provides guidance on securities laws requirements to clients involved in public and private M&A and private equity and leveraged buyout transactions, as well as debt and equity financings, divestitures, and spinoffs.

Anne is a key member of the firm’s multidisciplinary governance practice, helping corporate boards, companies, and their investors navigate a broad range of environmental, social, and governance considerations. In addition, Anne counsels companies implementing and administering a range of policies to address governance obligations, including insider trading, anti-hedging, and claw back policies. She is also a member of the firm’s FinTech, Blockchain, and Digital Assets practice, where she regularly advises on compensation and benefits programs involving cryptocurrency and digital assets.

viewpoints

Disclosure Guidance for Public Companies Affected By COVID-19

March 26, 2020 | Advisory | By Anne Bruno

Read about the SEC’s guidance on disclosures, including those related to COVID-19 and financial reporting issues, as well as on securities trading in light of the pandemic.
Read more
This alert covers Governor Cuomo’s executive order allowing corporations in New York to hold virtual-only shareholders meetings in light of COVID-19.
Read more
This article reviews guidance issued Friday, March 13, 2020 by the SEC’s Division of Corporation Finance to help public companies manage their upcoming annual meeting processes in light of COVID-19.
Read more

Closing the 8-K Insider Trading Gap

February 28, 2020 | Advisory | By Anne Bruno

On January 13th, the US House of Representatives overwhelmingly voted to pass legislation designed to prevent public company insiders from trading on corporate information ahead of the investing public during the period between the filing of a Form 8-K and the event triggering the filing (the “8-K gap period”). The US Senate version of the 8-K Trading Gap Act of 2019 (the “Bill”) was introduced on January 17th and awaits consideration.
Read more

Preparation for 2019 Fiscal Year-End SEC Filings and 2020 Annual Shareholder Meetings

January 23, 2020 | Advisory | By Megan Gates, John Condon, Anne Bruno

Read about regulatory developments affecting public companies as they prepare for fiscal year-end Securities and Exchange Commission filings and annual shareholder meetings.
Read more
On May 31, 2019, in Stein v. Blankfein, et. al., the Delaware Court of Chancery reaffirmed the Delaware Supreme Court’s holding in In re: Investors Bancorp, Inc. Stockholder Litigation (more information here) that the “entire fairness” standard applies with regard to director approval of director compensation. The Stein case builds on the precedent set in Investors Bancorp and provides additional insights.
Read more
Each year, Mintz provides an analysis of the regulatory developments that impact public companies as they prepare for their fiscal year-end filings with the Securities and Exchange Commission (the SEC) and their annual shareholder meetings. In this memorandum, we discuss key considerations to keep in mind as you embark upon the year-end reporting process in 2019.
Read more

Preparation for 2017 Fiscal Year-End SEC Filings and 2018 Annual Shareholder Meetings

January 30, 2018 | Advisory | By Pamela Greene, Anne Bruno, Megan Gates

As our clients and friends know, each year Mintz Levin provides an analysis of the regulatory developments that impact public companies as they prepare for their fiscal year-end filings with the Securities and Exchange Commission (the “SEC”) and their annual shareholder meetings.
Read more
Read less

News & Press

Press Release Thumbnail Mintz

Chambers USA has recognized 43 of Mintz’s practices and 88 of its attorneys in its 2025 guide to the country’s leading law firms. Of those featured in the guide, 17 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm expanded its rankings this year with three new practice area listings and 17 attorneys recognized for the first time or in additional categories.

Press Release Thumbnail Mintz
Mintz advised Cardurion Pharmaceuticals, Inc., a biotechnology company developing novel therapeutics to treat heart failure and other cardiovascular diseases, in a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity that will enable the Boston-based company to expand its drug discovery programs.
News Thumbnail Mintz
In Agenda, a Financial Times publication, Mintz Special Counsel Anne Bruno was quoted on company succession planning and how boards can effectively communicate the process and decision to candidates.
Press Release Thumbnail Mintz
Firm plays a key role in the largest health care acquisition to date in 2020.
Read less

podcasts

Member Jen Rubin is joined by Member Anne Bruno to discuss public company DEI reporting in today’s evolving federal legal landscape. This episode is part of a series of conversations designed to help employers navigate workplace changes and understand general legal considerations.

Read more
Read less

Events & Speaking

May
7
2025

Mintz’s Annual Employment Law Summit 2025 - Boston

One Financial Center, Boston, MA 02111

Speaker
May
7
2024
Employment Viewpoint Thumbnail
Speaker
Panelist
Feb
16
2023
Webinar Reference Image
Speaker
Jan
24
2023
Webinar Reference Image
Panelist
Oct
15
2022

The Future of Incentive Compensation & Blockchain

ABA 2022 Fall Tax Meeting

Hyatt Regency Dallas

Conference Reference Image
Speaker
Aug
17
2022

Cryptocurrency in Employee Benefits and Executive Compensation Arrangements

A live 90-minute premium CLE video webinar with interactive Q&A

Strafford Webinar

Webinar Reference Image
Speaker
May
6
2021
Webinar Reference Image
Speaker
Apr
15
2020
Webinar Reference Image
Read less

Recognition & Awards

  • Phi Beta Kappa

  • Chambers USA: Massachusetts - Employee Benefits & Executive Compensation (2025)

Read less